Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Meningococcal polysaccharide [serotypes A, C, W-135, Y] vaccine by CanSino Biologics for Neisseria meningitidis Infections: Likelihood of Approval
Meningococcal polysaccharide [serotypes A, C, W-135, Y] vaccine is under clinical development by CanSino Biologics and currently in Phase III...